The hepatocyte Elovl6 has been shown to regulate ceramide acyl-chain length and hepatic insulin sensitivity in mice linked to Pnpla3-mediated NAFLD [52]. Here, ELOVL6 is linked to metabolic dysfunction-associated steatotic liver disease.